{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:54:15Z","timestamp":1758970455083,"version":"3.37.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1097\/fjc.0b013e3181af6d9c","type":"journal-article","created":{"date-parts":[[2009,8,13]],"date-time":"2009-08-13T19:48:50Z","timestamp":1250192930000},"page":"163-168","source":"Crossref","is-referenced-by-count":35,"title":["Do Proton Pump Inhibitors Attenuate the Effect of Aspirin on Platelet Aggregation? A Randomized Crossover Study"],"prefix":"10.1097","volume":"54","author":[{"given":"Adam B","family":"Adamopoulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George N","family":"Sakizlis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efthimia G","family":"Nasothimiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioanna","family":"Anastasopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia","family":"Anastasakou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paraskevi","family":"Kotsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia","family":"Karafoulidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George S","family":"Stergiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-10-20210208","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/jama.2009.261","article-title":"Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome.","volume":"301","author":"Ho","year":"2009","journal-title":"JAMA"},{"key":"R2-10-20210208","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1503\/cmaj.082001","article-title":"A population-based study of the drug interaction between proton pump inhibitors and clopidogrel.","volume":"180","author":"Juurlink","year":"2009","journal-title":"CMAJ"},{"key":"R3-10-20210208","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","article-title":"Dominiczak A, et al; Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).","volume":"25","author":"Mancia","year":"2007","journal-title":"J Hypertens"},{"key":"R4-10-20210208","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0140-6736(96)01254-8","article-title":"Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product.","volume":"348","author":"Kelly","year":"1996","journal-title":"Lancet"},{"key":"R5-10-20210208","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1046\/j.1365-2036.2002.01355.x","article-title":"Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases.","volume":"16","author":"Serrano","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"R6-10-20210208","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1136\/bmj.310.6983.827","article-title":"Prophylactic aspirin and risk of peptic ulcer bleeding.","volume":"310","author":"Weil","year":"1995","journal-title":"BMJ"},{"key":"R7-10-20210208","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.cgh.2006.04.010","article-title":"Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin.","volume":"4","author":"American Gastroenterological Association; Wilcox","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R8-10-20210208","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/art.10148","article-title":"Guidelines for the management of rheumatoid arthritis: 2002 Update.","volume":"46","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R9-10-20210208","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1161\/CIRCULATIONAHA.106.181424","article-title":"Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association.","volume":"115","author":"Antman","year":"2007","journal-title":"Circulation"},{"key":"R10-10-20210208","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa012877","article-title":"Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use.","volume":"346","author":"Lai","year":"2002","journal-title":"N Engl J Med"},{"key":"R11-10-20210208","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0016-5085(96)70066-5","article-title":"Nonsteroidal anti-inflammatory drug and phospholipid prodrugs: combination therapy with antisecretory agents in rats.","volume":"111","author":"Lichtenberger","year":"1996","journal-title":"Gastroenterology"},{"key":"R12-10-20210208","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1046\/j.1365-2036.1997.00216.x","article-title":"Effect of omeprazole on the bioavailability of unmodified and phospholipid-complexed aspirin in rats.","volume":"11","author":"Giraud","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"R13-10-20210208","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1080\/003655200750024083","article-title":"Omeprazole does not interfere with the antiplatelet effect of low-dose aspirin in man.","volume":"35","author":"Inarrea","year":"2000","journal-title":"Scand J Gastroenterol"},{"key":"R14-10-20210208","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0090-9556(24)14906-9","article-title":"Involvement of cytochromes P-450 2E1 and 3A4 in the 5-hydroxylation of salicylate in humans.","volume":"27","author":"Dupont","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"R15-10-20210208","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.jacc.2007.07.051","article-title":"Platelet function monitoring in patients with coronary artery disease.","volume":"50","author":"Gurbel","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R16-10-20210208","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1160\/TH08-03-0198","article-title":"Response variability to aspirin as assessed by the platelet function analyzer (PFA)-100. A systematic review.","volume":"99","author":"Crescente","year":"2008","journal-title":"Thromb Haemost"},{"key":"R17-10-20210208","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2036.2006.02759.x","article-title":"Upper gastrointestinal bleeding associated with antiplatelet drugs.","volume":"23","author":"Ibanez","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"R18-10-20210208","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1001\/archinte.162.19.2248","article-title":"Might proton pump inhibitors prevent the antiplatelet effects of low- or very low-dose aspirin?","volume":"162","author":"Fernandez-Fernandez","year":"2002","journal-title":"Arch Intern Med"},{"key":"R19-10-20210208","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1046\/j.1365-2036.2000.00788.x","article-title":"Comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors.","volume":"14","author":"Stedman","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"R20-10-20210208","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.2165\/00003495-200161120-00011","article-title":"Lansoprazole: an update of its place in the management of acid-related disorders.","volume":"61","author":"Matheson","year":"2001","journal-title":"Drugs"},{"key":"R21-10-20210208","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00004836-199703000-00003","article-title":"The effects of oral doses of lansoprazole and omeprazole on gastric pH.","volume":"24","author":"Tolman","year":"1997","journal-title":"J Clin Gastroenterol"},{"key":"R22-10-20210208","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1365-2036.2003.01455.x","article-title":"Comparative pharmacokinetics and safety of lansoprazole oral capsules and orally disintegrating tablets in healthy subjects.","volume":"17","author":"Freston","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"R23-10-20210208","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2036.2004.02086.x","article-title":"A novel option in proton pump inhibitor dosing: lansoprazole orally disintegrating tablet dispersed in water and administered via nasogastric tube.","volume":"20","author":"Freston","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"R24-10-20210208","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/00498250410001685728","article-title":"Identification and relative contributions of human cytochrome P450 isoforms involved in the metabolism of glibenclamide and lansoprazole: evaluation of an approach based on the in vitro substrate disappearance rate.","volume":"34","author":"Naritomi","year":"2004","journal-title":"Xenobiotica"},{"key":"R25-10-20210208","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0090-9556(24)15348-2","article-title":"Measurement of cytochrome P450 gene induction in human hepatocytes using quantitative real-time reverse transcriptase-polymerase chain reaction.","volume":"28","author":"Bowen","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"R26-10-20210208","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jacc.2007.06.064","article-title":"Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study.","volume":"51","author":"Gilard","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R27-10-20210208","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1111\/j.1538-7836.2006.02162.x","article-title":"Influence of omeprazole on the antiplatelet action of clopidogrel associated to aspirin.","volume":"4","author":"Gilard","year":"2006","journal-title":"J Thromb Haemost"},{"key":"R28-10-20210208","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ahj.2008.09.017","article-title":"Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel.","volume":"157","author":"Siller-Matula","year":"2009","journal-title":"Am Heart J"},{"key":"R29-10-20210208","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1124\/dmd.31.10.1227","article-title":"Stereoselective metabolism of lansoprazole by human liver cytochrome P450 enzymes.","volume":"31","author":"Kim","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"R30-10-20210208","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s002280100374","article-title":"Role of CYP3A4 and CYP2C19 in the stereoselective metabolism of lansoprazole by human liver microsomes.","volume":"57","author":"Katsuki","year":"2001","journal-title":"Eur J Clin Pharmacol"},{"key":"R31-10-20210208","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1345\/aph.1E127","article-title":"Adverse reactions during imatinib and lansoprazole treatment in gastrointestinal stromal tumors.","volume":"39","author":"Severino","year":"2005","journal-title":"Ann Pharmacother"},{"issue":"Suppl 1","key":"R32-10-20210208","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1097\/00042737-199610001-00005","article-title":"Metabolic interactions of the proton-pump inhibitors lansoprazole, omeprazole and pantoprazole with other drugs.","volume":"8","author":"Meyer","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R34-10-20210208","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJM198411083111902","article-title":"Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase.","volume":"311","author":"Pedersen","year":"1984","journal-title":"N Engl J Med"},{"key":"R35-10-20210208","first-page":"616","article-title":"Low-dose enteric-coated aspirin: a practical approach to continuous-release low-dose aspirin and presystemic acetylation of human platelet cyclooxygenase.","volume":"108","author":"Jakubowski","year":"1986","journal-title":"J Lab Clin Med"},{"key":"R36-10-20210208","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/clpt.1987.128","article-title":"Pharmacokinetics of enteric-coated aspirin and inhibition of platelet thromboxane A2 and vascular prostacyclin generation in humans.","volume":"42","author":"Cerletti","year":"1987","journal-title":"Clin Pharmacol Ther"},{"key":"R37-10-20210208","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"}],"container-title":["Journal of Cardiovascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00005344-200908000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T18:56:18Z","timestamp":1739300178000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005344-200908000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/fjc.0b013e3181af6d9c","relation":{},"ISSN":["0160-2446"],"issn-type":[{"type":"print","value":"0160-2446"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}